LOS ANGELES--(BUSINESS WIRE)--Grant Life Sciences (OTC Bulletin Board: GLIF) announced today it has received notice from the U.S. Patent and Trademark Office that Patent No. 7,267,961—‘PEPTIDES FROM THE E7 PROTEIN OF HUMAN PAPILLOMA VIRUSES 16 AND 18 FOR DETECTING AND/OR DIAGNOSING CERVICAL AND OTHER HUMAN PAPILLOMA VIRUS ASSOCIATED CANCERS’—will issue tomorrow, Tuesday, Sept. 11, 2007.
